Skip to main content
Day.News — Local News. Real Community.
FLORIDA DAY NEWS
Local News. Real Community.
health
1 min read

Supreme Court Rules for Roundup Manufacturer in Cancer Case

The Supreme Court sided with the herbicide manufacturer in a case brought by a Missouri man who attributed his cancer to Roundup exposure. The ruling is expected to impact thousands of similar cases across the country.

07/18/2026 · Florida edition

Advertisement

Advertisement

Why it matters locally: Florida, with its significant agricultural sector, could see this ruling influence future liability claims related to agricultural chemicals. The legal precedent may impact how similar cases are handled in state courts, potentially affecting farmers, landscapers, and related industries.

The Supreme Court voted 7-2 to overturn a jury award in a case where a Missouri man claimed that exposure to Roundup caused his cancer. The decision favored the herbicide's manufacturer and is expected to affect the viability of thousands of pending lawsuits filed in courts nationwide. The jury had previously awarded the plaintiff compensation. The Supreme Court's majority opinion reversed that judgment, altering the legal standards that govern such claims. Dr. Chadi Nabhan, who authored a book examining the Monsanto trials and litigation over the herbicide, discussed the ruling's implications. Nabhan has written extensively on the legal battles surrounding Roundup exposure claims. Scientific research on the herbicide's health effects has produced conflicting findings. The International Agency for Research on Cancer classified glyphosate, Roundup's active ingredient, as probably carcinogenic in 2015. The U.S. Environmental Protection Agency reached a different conclusion in 2020, stating the chemical was unlikely to pose a cancer risk to humans at the exposure levels Americans typically encounter. Farmers, landscapers and homeowners have used Roundup for decades as a broad-spectrum herbicide. The product became one of the world's most widely used agricultural chemicals after its introduction in the 1970s. Plaintiffs in the litigation attributed their cancers to occupational or residential contact with the herbicide. They sought compensation from the manufacturer based on allegations that the company failed to adequately warn consumers about potential health risks. The court's decision removes a major avenue for additional lawsuits to proceed. Legal experts said the ruling sets a precedent that will make it substantially harder for future plaintiffs to bring similar cases to trial.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104108 articles8,220,515 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Florida

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Florida

health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Bay County faces alarming rise in stroke fatalities, medical community mobilizes

Bay County's stroke death rate hit a nearly two-decade high in 2024, prompting local hospitals to boost education and care efforts.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
health

Unvaccinated Lancaster County Resident Dies From Measles

Pennsylvania health officials announced Wednesday the death of an unvaccinated Lancaster County resident who tested positive for measles. This marks the fifth measles-related death reported in the state.

Read Story →
health

Dementia Patient Medication Use: A Michigan Case Study

A Michigan woman's case highlights family and guardian choices concerning sedating medications for agitated dementia patients. These medications are used in long-term care facilities. Federal initiatives aim to reduce their application.

Read Story →
health

HHS Report on Gender-Affirming Care Draws Scrutiny

A recent report from a federal health agency is prompting discussion regarding established healthcare models for transgender individuals. Critics characterize the report's framing of transgender identity in specific ways.

Read Story →
Scroll for more stories